PRESS-RELEASE ·Filed Mar 3, 2026
Press release · Announcement
Actionable Insight • Neutral
Monitor the presentation for any unexpected commentary on pipeline progress, partnerships, or funding plans, though material updates are unlikely given the nature of the event.
Final — all horizons settled through T+60d
PRQR ▼ -7.65% at T+60d
NEUTRAL call -7.65% · α vs SPY -17.73% · entry $1.70 → $1.57
T+1d
-0.59%
call -0.59% · α -0.01%
$1.69
settled 8mo ago
T+5d
+6.47%
call +6.47% · α +7.80%
$1.81
settled 8mo ago
T+20d
+0.59%
call +0.59% · α +5.00%
$1.71
settled 7mo ago
T+60d
-7.65%
call -7.65% · α -17.73%
$1.57
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
ProQR Therapeutics announced that its management will present at the Citizens Life Sciences Conference on March 11, 2026. The presentation will be webcast but is not expected to include new financial or clinical data.
Key Facts
- ProQR management to present at the Citizens Life Sciences Conference on March 11, 2026 at 3:25pm ET
- Presentation will be webcast and available for replay for approximately 30 days
- No new clinical, financial, or regulatory updates were disclosed in the press release
- Company continues to highlight its Axiomer™ RNA editing platform as a core focus
Financial Impact
Minimal near-term financial impact — presentation may increase investor visibility
Risk Factors
- No new data or guidance expected — limited potential for positive catalyst
- Low market cap ($166M) makes stock vulnerable to volatility based on speculative sentiment
Market Snapshot
Exchange
Nasdaq
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3248959 |
14 reports for PRQR
40% Hit rate @ T+5 Went positive at some point 3 of 5 best @ T+20▲ +11.88%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 6-K | $1.70 $1.66 | ▼ −2.35% | ▼ −1.68% | $1.34 (−21.18%) |
Sep 9, 2026 6w ago | 6-K | $1.99 $1.86 | ▼ −6.53% | ▼ −5.44% | $1.34 (−32.66%) |
Jul 16, 2026 14w ago | EFFECT | $1.67 $1.79 | ▼ −7.19% | ▼ −8.86% | $1.34 (+19.76%) |
Jun 25, 2026 17w ago | 6-K | $1.53 $1.81 | ▼ −18.30% | ▼ −16.13% | $1.34 (+12.42%) |
Jun 25, 2026 17w ago | 424B5 | $1.53 $1.81 | ▲ +18.30% | ▲ +16.13% | $1.34 (−12.42%) |
Jun 2, 2026 21w ago | 6-K | $1.47 $1.41 | ▼ −4.08% | ▼ −0.26% | $1.34 (−8.84%) |
May 12, 2026 24w ago | 6-K | $1.60 $1.51 | ▲ +5.63% | ▲ +5.70% | $1.34 (+16.25%) |
Apr 30, 2026 25w ago | 6-K | $1.57 $1.72 | ▲ +9.55% | ▲ +7.83% | $1.34 (−14.65%) |
Apr 30, 2026 25w ago | Press Release | $1.57 $1.72 | ▲ +9.55% | ▲ +7.83% | $1.34 (−14.65%) |
Apr 8, 2026 28w ago | 6-K | $1.98 $1.95 | ▼ −1.52% | ▼ −4.70% | $1.34 (−32.32%) |
Showing 10 of 14
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers